Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Congreso Oncológico ecancer - Liga Colombiana contra el Cáncer /
Cimavax - a lung cancer vaccine

17th - 18th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.01.17
Views: 2249

Dr Danay Saavedra - Centro de Inmunología Molecular, CIM, Cuba

Dr Saavedra speaks with ecancertv at the ecancer Colombian Cancer Congress about a novel anti-cancer vaccine, Cimavax.

She describes the immuno-targeting of the vaccine against EGF, and how blocking this pathway can halt cancer cell cycle progression.

Considering results from phase III studies, in treating advanced non-small cell lung cancer patients, Dr Saavedra reports a significant benefit for patients expression high levels of EGF.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation